Chronic lymphocytic leukaemia: A disease of activated monoclonal B cells

Best Practice and Research: Clinical Haematology

Volumn 23, Issue 1, 2010, Pages 33-45

  Damle, Rajendra N ^a,b   Calissano, Carlo ^a   Chiorazzi, Nicholas ^a,c  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

antigen; antigen receptor; B lymphocyte; cell proliferation; chronic lymphocytic leukaemia; kinetics

Indexed keywords

APTAMER; CD22 ANTIGEN; CD23 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; CD69 ANTIGEN; CD79B ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLIN D3; FC RECEPTOR IIB; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ALPHA; KI 67 ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; PEPTIDE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE ZAP 70; STAT1 PROTEIN; STAT3 PROTEIN;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE; CELL SURVIVAL; CHEMICAL ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; ERYTHROCYTE MEMBRANE; GENE MUTATION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN VARIABLE REGION; IN VIVO STUDY; LEUKEMIA CELL; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TELOMERE;

B-LYMPHOCYTES; CELL PROLIFERATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION;

EID: 77956646833     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2010.02.001     Document Type: Review

References (82)

1. V. Pascual, Y.J. Liu, and A. Magalski Analysis of somatic mutation in five B cell subsets of human tonsil J Exp Med 180 1 1994 329 339
2. J.C. Nolz, R.C. Tschumper, and B.T. Pittner ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype Leukemia 19 6 2005 1018 1024
3. R.N. Damle, F. Ghiotto, and A. Valetto B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes Blood 99 11 2002 4087 4093
4. A. Wiestner, A. Rosenwald, and T.S. Barry ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile Blood 101 12 2003 4944 4951
5. M. Crespo, F. Bosch, and N. Villamor ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia N Engl J Med 348 18 2003 1764 1775 (Pubitemid 36514707)
6. R.N. Damle, T. Wasil, and F. Fais Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 94 6 1999 1840 1847
7. G. Del Poeta, L. Maurillo, and A. Venditti Clinical significance of CD38 expression in chronic lymphocytic leukemia Blood 98 9 2001 2633 2639
8. P. Ghia, G. Guida, and S. Stella The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression Blood 101 4 2003 1262 1269
9. S. Deaglio, T. Vaisitti, and R. Billington CD38/CD19: a lipid raft-dependent signaling complex in human B cells Blood 109 12 2007 5390 5398
10. L. Chen, J. Apgar, and L. Huynh ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia Blood 105 5 2005 2036 2041
11. M. Sarfati CD23 and chronic lymphocytic leukemia Blood Cells 19 3 1993 591 596
12. J. Hulkkonen, L. Vilpo, and M. Hurme Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities Leukemia 16 2 2002 178 185
13. J. Vilpo, G. Tobin, and J. Hulkkonen Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells Eur J Haematol 75 1 2005 34 40
14. J. Borst, J. Hendriks, and Y. Xiao CD27 and CD70 in T cell and B cell activation Curr Opin Immunol 17 3 2005 275 281
15. R.N. Damle, S. Temburni, and C. Calissano CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells Blood 110 9 2007 3352 3359
16. B.T. Messmer, D. Messmer, and S.L. Allen In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells J Clin Invest 115 3 2005 755 764
17. C. Calissano, R.N. Damle, and G. Hayes In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia Blood 114 23 2009 4832 4842
18. C. Schmid, and P.G. Isaacson Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study Histopathology 24 5 1994 445 451
19. L.A. Soma, F.E. Craig, and S.H. Swerdlow The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma Hum Pathol 37 2 2006 152 159
20. L. Granziero, P. Ghia, and P. Circosta Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia Blood 97 9 2001 2777 2783
21. E.J. Schattner, J. Mascarenhas, and I. Reyfman Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity Blood 91 8 1998 2689 2697
22. E.A. Ranheim, M.J. Cantwell, and T.J. Kipps Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells Blood 85 12 1995 3556 3565
23. L. Trentin, R. Zambello, and R. Sancetta B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules Cancer Res 57 21 1997 4940 4947
24. P.E. Patten, A.G. Buggins, and J. Richards CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment Blood 111 10 2008 5173 5181
25. D. Serrano, J. Monteiro, and S.L. Allen Clonal expansion within the CD4+CD57+ and CD8+CD57 + T cell subsets in chronic lymphocytic leukemia J Immunol 158 3 1997 1482 1489
26. J.P. Halper, S.M. Fu, and A.B. Gottlieb Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens J Clin Invest 64 5 1979 1141 1148
27. N. Chiorazzi, S. Fu, and G. Montazeri T cell helper defect in patients with chronic lymphocytic leukemia J Immunol 1979 1221087 1221090
28. S. Scrivener, R.V. Goddard, and E.R. Kaminski Abnormal T-cell function in B-cell chronic lymphocytic leukaemia Leuk Lymphoma 44 3 2003 383 389
29. + T-cells in chronic lymphocytic leukemia Leuk Lymphoma 50 5 2009 788 801
30. A.G. Ramsay, A.J. Johnson, and A.M. Lee Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug J Clin Invest 118 7 2008 2427 2437
31. M. Muzio, B. Apollonio, and C. Scielzo Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy Blood 112 1 2008 188 195
32. I. Ringshausen, F. Schneller, and C. Bogner Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta Blood 100 10 2002 3741 3748
33. D.A. Frank, S. Mahajan, and J. Ritz B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues J Clin Invest 100 12 1997 3140 3148
34. D. Wolowiec, L. Ciszak, and A. Kosmaczewska Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia Haematologica 86 12 2001 1296 1304
35. C. Schrader, D. Janssen, and W. Klapper Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma Br J Cancer 93 8 2005 939 945
36. E. Endl, and J. Gerdes The Ki-67 protein: fascinating forms and an unknown function Exp Cell Res. 257 2 2000 231 237
37. D.C. Brown, and K.C. Gatter Ki67 protein: the immaculate deception? Histopathology 40 1 2002 2 11
38. N.P. Weng, L. Granger, and R.J. Hodes Telomere lengthening and telomerase activation during human B cell differentiation Proc Natl Acad Sci U S A 94 20 1997 10827 10832
39. L. Trentin, G. Ballon, and L. Ometto Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage Br J Haematol 106 3 1999 662 668
40. R.N. Damle, F.M. Batliwalla, and F. Ghiotto Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations Blood 103 2 2004 375 382
41. S. Lanham, T. Hamblin, and D. Oscier Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia Blood 101 3 2003 1087 1093
42. Cutrona G, Colombo M, Matis S, et-al. Clonal heterogeneity in CLL cells: response to surface IgM crosslinking is more efficient in CD38, ZAP-70 positive cells. Haematologica (in press).
43. D.G. Efremov, S. Gobessi, and P.G. Longo Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells Autoimmun Rev 7 2 2007 102 108
44. F. Lyko, D. Stach, and A. Brenner Quantitative analysis of DNA methylation in chronic lymphocytic leukemia patients Electrophoresis 25 10-11 2004 1530 1535
45. M.K. Yu, H. Bergonia, and A. Szabo Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation index Leuk Res 31 6 2007 773
46. M. Kanduri, N. Cahill, and H. Goransson Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia Blood 115 20 2010 296 305
47. U. Klein, T. Goossens, and M. Fischer Somatic hypermutation in normal and transformed human B cells Immunol Rev 1998 162261 162280
48. H.W. Schroeder Jr., and G. Dighiero The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire Immunol Today 15 6 1994 288 294
49. F. Fais, F. Ghiotto, and S. Hashimoto Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors J Clin Invest 102 8 1998 1515 1525
50. T.J. Hamblin, Z. Davis, and A. Gardiner Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood 94 6 1999 1848 1854
51. A. Krober, T. Seiler, and A. Benner V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia Blood 100 4 2002 1410 1416
52. A. Rosenwald, A.A. Alizadeh, and G. Widhopf Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia J Exp Med 194 11 2001 1639 1647
53. U. Klein, Y. Tu, and G.A. Stolovitzky Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells J Exp Med 194 11 2001 1625 1638
54. S.V. Ekholm, and S.I. Reed Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle Curr Opin Cell Biol 12 6 2000 676 684
55. D. Wolowiec, P. Deviller, and D. Simonin Cdk1 is a marker of proliferation in human lymphoid cells Int J Cancer 61 3 1995 381 388
56. J.T. Paul, E.S. Henson, and S. Mai Cyclin D expression in chronic lymphocytic leukemia Leuk Lymphoma 46 9 2005 1275 1285
57. N. Chiorazzi, K.R. Rai, and M. Ferrarini Chronic lymphocytic leukemia N Engl J Med 352 8 2005 804 815
58. N. Chiorazzi, and M. Ferrarini B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor Ann Rev Immunol 21 2003 21841 21894
59. E.A. Ranheim, and T.J. Kipps Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal J Exp Med 177 4 1993 925 935
60. P.G. Longo, L. Laurenti, and S. Gobessi The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease Leukemia 21 1 2007 110 120
61. R.A. Neese, S.Q. Siler, and D. Cesar Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation Anal Biochem 298 2 2001 189 195
62. M.K. Hellerstein, and R.A. Neese Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers Am J Physiol 263 5 Pt 1 1992 E988 1001
63. J.R. Rubini, V.P. Bond, and S. Keller DNA synthesis in circulating blood leukocytes labeled in vitro with H3-thymidine J Lab Clin Med 1961 58751 58762
64. T.S. Zimmerman, H.A. Godwin, and S. Perry Studies of leukocyte kinetics in chronic lymphocytic leukemia Blood 31 3 1968 277 291
65. H. Theml, G. Trepel, and P. Schick Kinetics of lymphocytes in chronic lymphocytic leukemia: studies using continuous 3H-thymidine infusion in two patients Blood 42623 1973
66. P. Dormer, H. Theml, and B. Lau Chronic lymphocytic leukemia: a proliferative or accumulative disorder? Leuk Res 7 1 1983 1 10
67. J. Defoiche, C. Debacq, and B. Asquith Reduction of B cell turnover in chronic lymphocytic leukaemia Br J Haematol 143 2 2008 240 247
68. R. van Gent, A.P. Kater, and S.A. Otto In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow Cancer Res 68 24 2008 10137 10144
69. B. Simonsson, and K. Nilsson 3H-thymidine uptake in chronic lymphocytic leukaemia cells Scand J Haematol 24 2 1980 169 173 (Pubitemid 10147360)
70. E. Montserrat, J. Sanchez-Bisono, and N. Vinolas Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance Br J Haematol 62 3 1986 567 575
71. S. Molica, and A. Alberti Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia Cancer 60 11 1987 2712 2716
72. A. Winkelstein, and C.G. Craddock Comparative response of normal human thymus and lymph node cells to phytohemagglutinin in culture Blood 29 4 Suppl. 1967 594 607
73. L.A. Smit, D.Y. Hallaert, and R. Spijker Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity Blood 109 4 2007 1660 1668
74. F. Caligaris-Cappio Role of the microenvironment in chronic lymphocytic leukaemia Br J Haematol 123 3 2003 380 388
75. M. Chilosi, G. Pizzolo, and F. Caligaris-Cappio Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia Cancer 56 2 1985 328 332
76. T. Renno, A. Attinger, and S. Locatelli Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo J Immunol 162 11 1999 6312 6315
77. P.K.A. Mongini, J.K. Inman, and H. Han Innate immunity and human B cell clonal expansion: effects on the recirculating B2 subpopulation J Immunol 175 9 2005 6143 6154
78. L.Z. Rassenti, S. Jain, and M.J. Keating Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia Blood 112 5 2008 1923 1930
79. L.Z. Rassenti, L. Hunynh, and T.L. Toy ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia N Engl J Med 351 9 2004 893 901
80. G. D'Arena, P. Musto, and G. Nunziata CD69 expression in B-cell chronic lymphocytic leukemia: a new prognostic marker? Haematologica 86 9 2001 995 996
81. T.D. Shanafelt, T.E. Witzig, and S.R. Fink Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia J Clin Oncol 24 28 2006 4634 4641
82. T.D. Shanafelt, D. Jelinek, and R. Tschumper Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia J Clin Oncol 24 19 2006 3218 3219 [Author reply pp. 3219-3220]